O-606
O-585 is a synthetic cannabinoid compound that has been studied for its potential effects on the endocannabinoid system. It is structurally related to other cannabinoids and acts as an agonist at the cannabinoid receptors, primarily CB1 and CB2.
Chemical Structure and Properties[edit | edit source]
O-585 is a derivative of the cannabimimetic class of compounds. Its chemical structure is characterized by a core indole or indazole moiety, which is common among synthetic cannabinoids. The specific substitutions on the indole ring and the length of the alkyl side chain can significantly influence its binding affinity and selectivity for cannabinoid receptors.
Pharmacology[edit | edit source]
O-585 acts as a full agonist at the CB1 and CB2 receptors, which are part of the G protein-coupled receptor family. Activation of these receptors by O-585 can lead to a variety of physiological effects, including modulation of neurotransmitter release, alteration of pain perception, and changes in mood and appetite.
Mechanism of Action[edit | edit source]
The mechanism of action of O-585 involves the activation of cannabinoid receptors, which are widely distributed in the central nervous system and peripheral nervous system. Upon binding to these receptors, O-585 can influence intracellular signaling pathways, such as the inhibition of adenylate cyclase and the modulation of ion channels.
Potential Applications[edit | edit source]
Research into O-585 and similar compounds is ongoing, with potential applications in the treatment of conditions such as chronic pain, inflammation, and neurological disorders. However, due to its status as a research chemical, O-585 is not approved for medical use and is primarily used in laboratory settings to study the endocannabinoid system.
Safety and Legal Status[edit | edit source]
As a synthetic cannabinoid, O-585 may pose risks similar to those associated with other compounds in this class, including psychotropic effects and potential for abuse. The legal status of O-585 varies by jurisdiction, and it is often subject to regulation as a controlled substance.
Research and Development[edit | edit source]
Ongoing research aims to better understand the pharmacokinetics and pharmacodynamics of O-585, as well as its long-term effects on health. Studies are also exploring its potential therapeutic benefits and risks.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD